INS and Hypoglycemia: Thus, the risk of nocturnal confirmed hypoglycemia was significantly lower in the once-daily IDegAsp group (OR 0.51, 95% CI 0.27 to 0.95, I2 = 66.0; Figure 4D) than that in the once-daily basal insulin group.